Microprocess. Microsystems | 2021
Artificial intelligence hospital hardware system and clinical observation of molecular heparin sodium in hemodialysis patients
Abstract
ABSTRACT Mobile technology is changing the way the patient is undergoing medical treatment. The patient is integrated to manage their health, smartphone, and tablet. The mobile device, such as a patient monitoring system, provides easy-to-doctor real-time patient information. It is easier to communicate with patients and doctors. Mobile health care offers several advantages; however, there are also disadvantages to using these mobile technologies. Necessary to solve privacy is one of the few problems. The patient will not pay more attention. It will focus on mobile medical privacy issues. Based on the mobile medical privacy protection laws, will show how to protect the patient of intelligence Privacy-Preserving Approach for Mobile Healthcare (PAMH). Based on the smartphone s application and access control mechanism, the solution is designed to allow patients to develop their privacy settings, the disclosure of confidential medical information. Various aspects of solution are to use the proposed method; it is defined by whether the patient s privacy policy is shown in the actual scenario. Low Molecular Weight Heparin (LMWH) has been extensively studied; it has become the preferred treatment for several indications, including pulmonary embolism. Effectiveness of their blood dialysis, but is believed to be similar to that of Unfractionated Heparin (UFH), there is a discussion that the risk of their safety is still renal disorder in a patient bio-enrichment. Compared to unfractionated heparin for Extracorporeal Circulation (ECC) anticoagulant, Sodium has been introduced as a viable diagnostic tool for assessing the Na\u202f+\u202fcontent of the tissue in kidney disease patients.